Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:53 PM EDT
453.08quote price arrow down-1.52 (-0.33%)
Volume
48,093
Close
454.60quote price arrow up+13.88 (+3.15%)
Volume
9,483,778
52 week range
63.64 - 497.49
Loading...
  • Open439.79
  • Day High458.50
  • Day Low438.79
  • Prev Close440.72
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low63.64
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap183.499B
  • Shares Out403.65M
  • 10 Day Average Volume15.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change335.15

KEY STATS

  • Open439.79
  • Day High458.50
  • Day Low438.79
  • Prev Close440.72
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low63.64
  • 52 Week Low Date09/24/20
  • Market Cap183.499B
  • Shares Out403.65M
  • 10 Day Average Volume15.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change335.15

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)56.75
  • Fwd P/E (NTM)10.33
  • EBITDA (MRQ)3.918B
  • ROE (MRQ)72.43%
  • Revenue (MRQ)7.02B
  • Gross Margin (MRQ)84.20%
  • Net Margin (MRQ)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:3703:37
Pfizer, Moderna report positive topline results for vaccine in ages 5-11

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
352.99+13.73+4.05%
ILMN
Illumina Inc
433.20-1.39-0.32%
REGN
Regeneron Pharmaceuticals Inc
646.51-0.55-0.09%
BIIB
Biogen Inc
293.20+3.88+1.34%
GRFS
Grifols SA
15.36+0.07+0.46%